Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Publication year range
1.
Clín. investig. ginecol. obstet. (Ed. impr.) ; 50(4): [100901], Oct-Dic, 2023. tab
Article in Spanish | IBECS | ID: ibc-226527

ABSTRACT

Objetivo: Analizar el nivel de conocimiento entre profesionales sanitarios de atención primaria sobre endometriosis e identificar sus necesidades formativas en esta materia. Diseño: Estudio descriptivo realizado en atención primaria del Área de Salud de Gran Canaria, mediante cuestionario online anónimo. Resultados: Ciento diecinueve especialistas en medicina de familia y comunitaria y 37 matronas respondieron el cuestionario. El 54,6% de profesionales médicos y el 67,6% de matronas consideran escaso su conocimiento sobre endometriosis. Menos del 50% de profesionales conoce la guía de atención a las mujeres con endometriosis en el Sistema Nacional de Salud. Los síntomas más frecuentes relacionados con endometriosis son: dismenorrea moderada/severa, dolor pélvico crónico, esterilidad. Los menos relacionados son los digestivos y las alteraciones urinarias catameniales. Un 80% de profesionales médicos señalan como menor de 10 el número anual de pacientes en las que piensan que puedan tener endometriosis y menos de 20 para el 75% de matronas. El 40% de profesionales médicos trataría a una paciente con solo dismenorrea y sin planes de gestación con anticonceptivos orales; el 8% considera que el dolor con la menstruación es algo común. El 25% de profesionales especialistas en medicina de familia y comunitaria señalan la terapia de larga duración con antiinflamatorios no esteroideos como tratamiento de primera línea. Menos del 25% de ellos derivarían al especialista en Ginecología con solo sospechar endometriosis. Mayoritariamente los profesionales manifiestan interés en mejorar su formación en endometriosis. El 94,6% de las matronas consideran que tienen un papel estratégico en el manejo de pacientes con endometriosis. Conclusión: La demora en el diagnóstico de la endometriosis se debe en parte al desconocimiento de la enfermedad. Los profesionales de atención primaria constituyen la primera línea de atención sanitaria.(AU)


Objective: To analyze the level of knowledge of endometriosis in primary care doctors and midwives and to identify their training needs in this area. Design: Descriptive study conducted in the primary care services of the Health Area of Gran Canaria, through an anonymous online questionnaire. Results: One hundred and nineteen doctors and 37 midwives completed the questionnaire; 54.6% of doctors and 67.6% of midwives considered that their knowledge about endometriosis was poor. Less than 50% of healthcare professionals knew the National System of Health's guidelines for the management of women with endometriosis. Symptoms most frequently associated to endometriosis included: moderate/severe dysmenorrhea, chronic pelvic pain and sterility. Less frequently related ones included: digestive symptoms and catamenial urinary disorders; 80% of doctors suspected endometriosis in <10 women per year; 75% of midwives suspected this condition in <20 women per year; 40% of doctors would prescribe oral contraceptives to patients with dysmenorrhea who were not planning pregnancy; 8% of doctors considered that menstruation-associated pain was common. Medical therapy was the most frequently chosen first-line treatment; 25% of doctors would choose long-term NSAIDs therapy as a first-line treatment; less than 25% of them would refer a patient to the Gynecology service only for suspected endometriosis. Most health professionals expressed their interest in improving their knowledge about endometriosis; 94.6% of midwives considered that they played a strategic role in the identification and management of patients with endometriosis. Conclusion: Delays in the diagnosis of endometriosis are partially due to ignorance of the disease. Primary care professionals constitute the first line of health care. In this context, it is essential to develop specific training strategies, which would be welcome by health professionals.(AU)


Subject(s)
Humans , Female , Endometriosis/nursing , Endometriosis/prevention & control , Midwifery , Health Personnel/education , Health Literacy , Spain , Gynecology , Family Practice , Primary Health Care , Epidemiology, Descriptive , Surveys and Questionnaires
2.
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.) ; 49(5): [e101939], jul.- ago. 2023. tab
Article in English | IBECS | ID: ibc-223262

ABSTRACT

Introduction This study analyzed the impact of patients’ age, sex, vaccination, immunosuppressive treatment, and previous comorbidities on the risk of developing persistent COVID-19 or SARS-CoV-2 virus reinfection. Method Population-based observational retrospective study of a cohort of 110,726 patients aged 12 years or older, who were diagnosed with COVID-19 between June 1st, 2021 and February 28th, 2022 in the island of Gran Canaria. Results 340 patients suffered reinfection. The combination of advanced age, female sex and lack of complete or incomplete vaccination against COVID-19 was strongly predictive of reinfection (p<0.05). In the 188 patients who developed persistent COVID-19, the persistence of symptoms was more frequent in adult patients, women, and patients with a diagnosis of asthma. Complete vaccination was associated with a lower risk of reinfection ([OR] 0.05, 95%CI 0.04–0.07; p<0.05) and of developing persistent COVID-19 ([OR] 0.07, 95%CI 0.05–0.10; p<0.05). None of the patients with reinfection or persistent COVID-19 died during the period of the study Conclusions This study confirmed the link between age, sex, asthma and risk of persistent COVID-19. It was not possible to define the patient's comorbidities as a factor that influences the development of reinfection, but its association with age, sex, type of vaccine and hypertension was demonstrated. Higher vaccination coverage was associated with a lower risk of persistent COVID-19 or SARS-CoV-2 reinfection (AU)


Introducción Se analizó el impacto de la edad, el sexo, la vacunación, el tratamiento inmunosupresor y las comorbilidades previas del paciente sobre la condición de riesgo de desarrollar COVID-19 persistente o reinfección por el virus del SARS-CoV-2. Método Estudio retrospectivo observacional de base poblacional en una cohorte de 110.726 pacientes de 12 o más años de edad diagnosticados de COVID-19 entre el 1 de junio de 2021 y el 28 de febrero de 2022 en la isla de Gran Canaria. Resultados Trescientos cuarenta pacientes sufrieron reinfección por COVID-19. La combinación de edad avanzada, sexo femenino y falta de vacunación completa o incompleta contra la COVID-19 fue fuertemente predictiva de reinfección (p<0,05). En los 188 pacientes que desarrollaron COVID-19 persistente, la persistencia de síntomas fue más frecuente en pacientes en edad adulta, mujeres y pacientes con diagnóstico de asma. La vacunación completa se asoció con un menor riesgo de reinfección ([OR] 0,05, IC 95% 0,04-0,07; p <0,05) y de desarrollar COVID-19 persistente ([OR] 0,07, IC 95% 0,05-0,10; p <0,05). Ninguno de los pacientes con reinfección o COVID-19 persistente falleció durante el período del estudio. Conclusiones Este estudio confirmó el vínculo entre la edad, el sexo, el asma y el riesgo de COVID-19 persistente. No se pudo definir las comorbilidades del paciente como factor que influye en el desarrollo de reinfección, pero sí se demostró su asociación con edad, sexo e hipertensión arterial. Una mayor cobertura de vacunación se asoció a un menor riesgo de COVID-19 persistente o reinfección por SARS-CoV-2 (AU)


Subject(s)
Humans , Male , Female , Child , Adolescent , Young Adult , Adult , Middle Aged , Aged , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Pandemics , Recurrence , Retrospective Studies , Risk Factors , Spain/epidemiology
3.
Semergen ; 49(5): 101939, 2023.
Article in English | MEDLINE | ID: mdl-36889055

ABSTRACT

INTRODUCTION: This study analyzed the impact of patients' age, sex, vaccination, immunosuppressive treatment, and previous comorbidities on the risk of developing persistent COVID-19 or SARS-CoV-2 virus reinfection. METHOD: Population-based observational retrospective study of a cohort of 110,726 patients aged 12 years or older, who were diagnosed with COVID-19 between June 1st, 2021 and February 28th, 2022 in the island of Gran Canaria. RESULTS: 340 patients suffered reinfection. The combination of advanced age, female sex and lack of complete or incomplete vaccination against COVID-19 was strongly predictive of reinfection (p<0.05). In the 188 patients who developed persistent COVID-19, the persistence of symptoms was more frequent in adult patients, women, and patients with a diagnosis of asthma. Complete vaccination was associated with a lower risk of reinfection ([OR] 0.05, 95%CI 0.04-0.07; p<0.05) and of developing persistent COVID-19 ([OR] 0.07, 95%CI 0.05-0.10; p<0.05). None of the patients with reinfection or persistent COVID-19 died during the period of the study. CONCLUSIONS: This study confirmed the link between age, sex, asthma and risk of persistent COVID-19. It was not possible to define the patient's comorbidities as a factor that influences the development of reinfection, but its association with age, sex, type of vaccine and hypertension was demonstrated. Higher vaccination coverage was associated with a lower risk of persistent COVID-19 or SARS-CoV-2 reinfection.


Subject(s)
Asthma , COVID-19 , Adult , Humans , Female , SARS-CoV-2 , COVID-19/epidemiology , Spain/epidemiology , Reinfection , Retrospective Studies , Asthma/epidemiology
4.
Rev Esp Quimioter ; 36(2): 180-186, 2023 Apr.
Article in Spanish | MEDLINE | ID: mdl-36709415

ABSTRACT

OBJECTIVE: To analyze the frequency of influenza and SARS-CoV-2 co-infections, as well as the differences in the course of disease (risk of mortality, hospital and intensive care admissions) in patients infected with the SARS-CoV-2 virus in relation to flu vaccination status in the 2021-2022 season. METHODS: Population-based observational retrospective study in a cohort of 19,850 patients diagnosed with COVID-19 between June 1, 2021 and February 28, 2022 on the island of Gran Canaria. RESULTS: A total of 1,789 patients (9%) diagnosed with COVID-19 had received flu vaccinations. 13,676 people (68.9%) had a full course of COVID-19 vaccinations. In the period between June 1, 2021 and February 28, 2022, 8 cases of flu and COVID-19 coinfection were recorded. Hypertension (18.5%), asthma (12.8%) and diabetes (7.2%) were the most frequent comorbidities. There were 147 deaths (0.7%). Older patients ([OR] 1.11 95% CI 1.09-1.13) and people with cancer ([OR] 4.21 95% CI 2.58-6.89) had a higher risk of dying from COVID-19 (p<0.05). Female sex was noted as a protective factor ([OR] 0.61 95% CI 0.40-0.92). CONCLUSIONS: Old age, male sex and cancer were independent prognostic factors for mortality. Three doses of SARS-CoV-2 vaccines and influenza vaccines were highly effective in preventing COVID-19-related deaths and hospital admissions. These findings suggest that flu vaccination can help control the pandemic.


Subject(s)
COVID-19 , Coinfection , Influenza Vaccines , Influenza, Human , Female , Humans , Male , COVID-19 Vaccines , Disease Progression , Influenza, Human/prevention & control , Retrospective Studies , SARS-CoV-2 , Spain , Vaccination
5.
Eur Rev Med Pharmacol Sci ; 21(18): 4014-4021, 2017 Sep.
Article in English | MEDLINE | ID: mdl-29028102

ABSTRACT

Microsphere and particle technology represent the next-generation agents that have formed the basis of interventional oncology, an evolving subspecialty of interventional radiology. One of these platforms, yttrium-90 microspheres, is increasingly being used as a treatment modality for primary and secondary liver tumors. Due to the widespread use of radioembolization, a comprehensive review of the methodologic and technical considerations seems to be mandatory. This article summarizes the expert discussion and report from Mediterranean Interventional Oncology Live Congress (MIOLive 2017) that was held in Rome, Italy, integrating evidence-reported literature and experience-based perceptions, to assist not only residents and fellows who are training in interventional radiologists but also practicing colleagues who are approaching to this intra-arterial treatment.


Subject(s)
Embolization, Therapeutic , Liver Neoplasms/therapy , Contrast Media/chemistry , Humans , Italy , Liver/anatomy & histology , Liver/diagnostic imaging , Liver/pathology , Liver Neoplasms/pathology , Microspheres , Yttrium Radioisotopes/chemistry
6.
Gac. sanit. (Barc., Ed. impr.) ; 14(5): 338-345, sep. -oct. 2000.
Article in Es | IBECS | ID: ibc-2800

ABSTRACT

Objetivo: Estudiar la prevalencia y características del hábito tabáquico de los estudiantes de COU y 2.o de Bachillerato de Gran Canaria en el curso académico 1996-97.Métodos: Estudio transversal sobre una muestra de 931 alumnos obtenida por un método bietápico por conglomerados y estratificación en función del hábitat y del tipo de centro docente. La información se recogió mediante un cuestionario autoadministrado que incluía variables de identificación, características del consumo de tabaco, entorno familiar y social y factores actitudinales sobre las medidas restrictivas. Resultados: El 66,8 por ciento de los entrevistados son no fumadores y el 4 por ciento exfumadores. De los restantes, el 18,1 por ciento son fumadores habituales y el 11,1 por ciento ocasionales. La prevalencia de tabaquismo es mayor en las mujeres (p < 0,001), no difiriendo la cantidad de cigarrillos consumidos según el sexo. Se iniciaron al consumo de tabaco, en promedio, a los 15 años (ñ 1,5 años). No se aprecian diferencias significativas entre el consumo de tabaco de los padres y de los hijos, pero sí con el de los amigos o hermanos: el 87,5 por ciento de los fumadores tienen amigos que también lo son y el 42 por ciento algún hermano. Al inicio del hábito, sólo el 12 por ciento de los padres permiten fumar a sus hijos, llegando al 50 por ciento a medida que tienen más edad, siendo más permisivos con el sexo masculino. Conclusiones: La prevalencia de tabaquismo y la edad de inicio son menores en nuestra población que las observadas en otros estudios. La actuación debe centrarse en evitar la incorporación al consumo de tabaco creando un ambiente social y familiar en el que el tabaquismo sea considerado un comportamiento excepcional (AU)


Subject(s)
Adolescent , Adult , Male , Female , Humans , Attitude to Health , Adolescent Behavior , Spain , Tobacco Use Disorder , Sex Distribution , Atlantic Islands , Cross-Sectional Studies
7.
Gac Sanit ; 14(5): 338-45, 2000.
Article in Spanish | MEDLINE | ID: mdl-11187451

ABSTRACT

OBJECTIVE: To study the prevalence and characteristics of tobacco use in the last years of the high school students in Gran Canaria (Spain) enrolled in the 1996-1997 academic year. METHODS: Cross-sectional study of a sample of 931 students obtained through a two-stage method by conglomerates and stratification based on habit and type of educational institution. The information was gathered from a personal questionnaire that included identification variables, characteristics of tobacco consumption, family and social environment and attitudinal factors about restrictive measures. RESULTS: 66.8% of participants were non-smokers and 4% ex-smokers. Of the remaining, 18.1% were habitual smokers and 11.1% occasional smokers. The use of tobacco is higher in women than in men (p < 0.001) even though the quantity of tobacco consumed is the same. On the average, the consumption of tobacco begins at 15 years (+/- 1.5 years). There is not significant relation between tobacco use in parents and their children; however, there is a relation between tobacco use in those questioned and their siblings and friends: 87.5% of smokers had friends who also smoked and 42% a sibling who smoked. When those questioned started, only 12% of their parents had allowed them to smoke, reaching 50% when they were interviewed. Parents were more permissive with regard to tobacco consumption with males. CONCLUSIONS: The prevalence of tobacco use and age at starting are lower in our population than in other studies. Any action taken should concentrate on avoiding the incorporation of tobacco into daily life, creating a social and family environment where the use of tobacco is exceptional.


Subject(s)
Adolescent Behavior , Attitude to Health , Smoking/epidemiology , Adolescent , Adult , Atlantic Islands/epidemiology , Cross-Sectional Studies , Female , Humans , Male , Sex Distribution , Smoking/psychology , Spain/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...